Company Filing History:
Years Active: 1998-2000
Title: Noriaki Seki: Innovator in Biotechnological Advancements
Introduction
Noriaki Seki is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of DNA encoding and its applications in medical diagnostics.
Latest Patents
Noriaki Seki holds two notable patents. His latest invention involves DNA encoding horseshoe crab amebocyte lysate factor G subunit A. This invention relates to a DNA sequence represented by SEQ ID No. 1 and an amino acid sequence coded by this DNA. It also pertains to a DNA and an amino acid sequence of subunit A of (1→3)-β-glucan sensitive factor derived from horseshoe crab amebocytes. This invention demonstrates a potent affinity to (1→3)-β-D-glucan found in the cell walls of fungi. Consequently, it is useful for diagnosing fungal diseases and serves as an antimicrobial or eradicating agent of fungi when combined with antifungal agents.
Career Highlights
Throughout his career, Noriaki Seki has worked with notable companies, including Seikagaku Kogyo Kabushiki Kaisha and Seikagaku Corporation. His work has significantly impacted the field of biotechnology, particularly in developing innovative solutions for medical applications.
Collaborations
Noriaki Seki has collaborated with esteemed colleagues such as Sadaaki Iwanaga and Tatsushi Muta. Their joint efforts have contributed to advancements in the understanding and application of biotechnological innovations.
Conclusion
Noriaki Seki's contributions to biotechnology, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatments.